TreatSMA has responded to draft nusinersen guidance
TreatSMAS has submitted its comments to the draft NICE guidance on nusinersen.
TreatSMAS has submitted its comments to the draft NICE guidance on nusinersen.
TreatSMAS has submitted its comments to the draft NICE guidance on nusinersen.
Yesterday in London and Manchester we stood demanding the right for the SMA community to access the only treatment, Spinraza.
Yesterday in London and Manchester we stood demanding the right for the SMA community to access the only treatment, Spinraza.
On Friday 7th September TreatSMA and the community will stand alongside each other and hold a protest against the proposed decision to not recommend the life-saving drug Spinraza for treating children and adults.
On Friday 7th September TreatSMA and the community will stand alongside each other and hold a protest against the proposed decision to not recommend the life-saving drug Spinraza for treating children and adults.